Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications
Pierre Chambon, a pioneer of molecular biology and gene regulation in eukaryotes.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 01, 2026
HIF1 inhibition targets tumoral and myeloid cells, and is a promising therapy for metastatic castration-resistant prostate cancer.
Journal: Cell death & disease
Published: August 29, 2025
Enhanced proteasome activity in perifascicular myofibres is a hallmark of dermatomyositis and its inhibition is efficient in preclinical models.
Journal: Annals of the rheumatic diseases
Published: April 30, 2025
Impaired vitamin D signaling reveals neutrophils as key drivers of prostate cancer dissemination.
Journal: EMBO molecular medicine
Published: April 13, 2025
New insights of vitamin D-based therapy for prostate cancer
Journal: Medecine sciences : M/S
Published: March 03, 2025
Targeting pre-existing club-like cells in prostate cancer potentiates androgen deprivation therapy.
Journal: EMBO molecular medicine
Published: January 07, 2025
p53-loss induced prostatic epithelial cell plasticity and invasion is driven by a crosstalk with the tumor microenvironment.
Journal: Cell death & disease
Published: June 17, 2024
Experimental myositis: an optimised version of C-protein-induced myositis.
Journal: RMD open
Published: May 21, 2024
A vitamin D-based strategy overcomes chemoresistance in prostate cancer.
Journal: British journal of pharmacology
Published: November 29, 2023
Hope for a new treatment for castration-resistant prostate cancer
Journal: Medecine sciences : M/S
Published: November 09, 2023
LSD1 inhibition circumvents glucocorticoid-induced muscle wasting of male mice.
Journal: Nature communications
Published: June 09, 2023
Last Updated: 09/26/2026